← ALL WORKLAUNCHED / SCALING

BUILD

Turning problem foot care into a pharmacy and e-commerce routine

BRAND STRATEGYPRODUCT DEVELOPMENTOEM·ODMQUASI-DRUGCLINICALPHARMACYCOMMERCE
DERMASOME / STEP 1–3 FOOT DERMACOSMETIC ROUTINE project hero
20,000+ UNITS / 3 MONTHS
01BRAND & PRODUCT

BRAND & PRODUCT

DERMASOME / STEP 1–3 FOOT DERMACOSMETIC ROUTINE

02MARKET

MARKET

KOREA / PHARMACY → E-COMMERCE → RETAIL

03BUSINESS PROBLEM

BUSINESS PROBLEM

Foot and nail concerns create significant discomfort, but the category also carries treatment imagery and distrust of exaggerated advertising. It needed a credible, repeatable management routine—not a single product.

04BLD:B DIAGNOSIS

BLD:B DIAGNOSIS

We positioned the STEP 1 quasi-drug as the authority SKU, then designed follow-up stages connecting exfoliation, moisturization and skin condition. Pharmacy credibility came first, followed by e-commerce expansion.

05SCOPE

SCOPE

  • Category, target and positioning
  • Three-step product portfolio
  • Formula, sensorial and manufacturing development
  • Quasi-drug route and labeling
  • Clinical and antimicrobial proof
  • Campaign, product page and advertising direction
  • Pharmacy and e-commerce channel structure
06MANUFACTURING

MANUFACTURING

We selected specialized quasi-drug and cosmetic manufacturers by item and directly managed formula, filling, package compatibility and quality issues.

07MARKET ENTRY

MARKET ENTRY

  • PHARMACY 200+
  • COUPANG
  • NAVER SMARTSTORE
  • OLIVE YOUNG PREPARATION
08PROOF

PROOF

  • Antimicrobial tests across five microorganisms
  • Human-study design for exfoliation, roughness and moisturization
  • Before-and-after visuals
  • Consumer review and CS language
09CONTENT & SALES

CONTENT & SALES

Instead of sensationalizing problem areas, we converted step-by-step care logic, real-use scenes, antimicrobial, exfoliation and moisturizing proof, and review language into product-specific content.

10RESULT & NEXT

RESULT & NEXT

The brand built experience of more than 20,000 units sold within three months and a base of over 200 pharmacy doors. Sales, returns and quality data were fed into the next manufacturer and follow-up SKU decisions.

NEXT CASE

REBUILD

Seven products already selling. One system built for two markets.

↗